Human [Ala31]insulin-like Growth Factor-I ([Ala31]IGF-I) is an analogue of human IGF-I which has an Alanine substitution in place of Tyrosine at position 31 of the human IGF-I sequence. [Ala31]IGF-I has normal binding to acid-stripped human serum binding proteins but has reduced binding to the type 1 IGF receptor and to the insulin receptor compared to IGF-I. It has a slightly higher affinity for the type 1 IGF receptor than [Leu24]IGF-I and [Leu60]IGF-I and is able to elicit a weak biological response through this receptor. It is a useful analogue for studying the balance of effects of IGF-I through the type 1 receptor and IGF binding proteins.
This product is manufactured in Australia by GroPep Bioreagents.
| Size | 100 µg |
| Source Species | Recombinant |
| Expression System | Ecoli |
| Storage | 2-8°C |
| Alternative Names | Human [Ala31] Insulin-like Growth Factor-I ([Ala31] IGF-I) |

![Human [Ala31] IGF-I](https://eaglebio.com/wp-content/uploads/2025/08/GroPep-logo-header-1.png)